1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow EF-1 Peptide: new trials by email Literature Review of EF-1 Peptide trials Research Report on EF-1 Peptide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas EF-1 Peptide, EF-2 Peptide, PXFK Peptide - Ewing's Sarcoma, Rhabdomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 30 | 1996-12-23 | 2019-11-29 |
Rhabdomyosarcoma (1) · Sarcoma, Ewing (1)
National Cancer Institute (NCI) (1)
United States (1)